Denine Baldor, NP
Nurse Practitioner · Berkeley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 11
- 1 carrier
- Office
- 1
- Since medical school
- 16 years
- Yale University School of Medicine, 2010
Offices
1 location · Mark David Levine MD Professional Corporation · 165 clinicians in this group
Plans that list them
11 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Denine Baldor’s office at (510) 899-6220 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Original Medicare doctor bills
$3,108
Medicare paid this office $3,108 for 11 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
11 Original Medicare patients in 2024. Average age 48 · 85 and older 0% · Health risk score 0.70. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
The office billed $22,246, Medicare allowed $5,154 and paid $3,108; for 39 services of 2 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 11 | 39 | 48 | 0.70 | $22,246 | $3,108 |
| 2013 | 51 | 276 | 61 | 0.94 | $21,945 | $9,958 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2013: 4 services
| Return visit (30+ min) | 43 | $6,569 | $58 |
| Short return visit (20+ min) | 21 | $1,006 | $34 |
| Psychotherapy with evaluation and management visit, 30 minutes | 25 | $904 | $23 |
| Short return visit | 16 | $343 | $20 |
Medicaid work
$149,859 in 2024
Medicaid paid $149,859 for 937 billed services this clinician did in 2024, up to 88 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 937 | $149,859 |
| 2024 | 937 | 1 | 88 | $149,859 |
| 2023 | 844 | 1 | 93 | $147,829 |
| 2022 | 814 | 2 | 88 | $214,591 |
| 2021 | 388 | 3 | 77 | $95,773 |
| 2020 | 82 | 2 | 26 | $22,017 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 844 | $147,829 |
2022
| Return visit (30+ min) | 771 | $201,559 |
| Psychiatric diagnostic evaluation with medical services | 43 | $13,032 |
2021
| Return visit (30+ min) | 343 | $85,255 |
| Short return visit (20+ min) | 33 | $6,629 |
| Psychiatric diagnostic evaluation with medical services | 12 | $3,890 |
2020
| Psychiatric diagnostic evaluation with medical services | 50 | $14,755 |
| Return visit (30+ min) | 32 | $7,263 |
Drugs they prescribed that Part D paid
$113,638
Pharmacies billed $113,638 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 858) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
819 generic and 39 brand-name prescriptions · $113,638 in drug cost · 108 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Nuplazid | Parkinson's psychosis | 12 | $58,621 | $4,885 |
| Aripiprazole | None | 41 | $11,070 | $270 |
| Vyvanse | None | 15 | $5,574 | $372 |
| Duloxetine | None | 66 | $3,348 | $51 |
| Bupropion Xl | None | 72 | $3,198 | $44 |
See all 25 drugs
| Nuplazid | Parkinson's psychosis | 12 | $58,621 | $4,885 |
| Aripiprazole | None | 41 | $11,070 | $270 |
| Vyvanse | None | 15 | $5,574 | $372 |
| Duloxetine | None | 66 | $3,348 | $51 |
| Bupropion Xl | None | 72 | $3,198 | $44 |
| Desvenlafaxine Succinate Er | None | 13 | $2,028 | $156 |
| Quetiapine | None | 42 | $1,520 | $36 |
| Gabapentin | None | 51 | $1,009 | $20 |
| Venlafaxine Hcl Er | None | 22 | $1,000 | $45 |
| Lamotrigine | None | 29 | $924 | $32 |
| Buspirone | None | 27 | $857 | $32 |
| Mirtazapine | None | 25 | $804 | $32 |
| Escitalopram | None | 44 | $679 | $15 |
| Vilazodone | None | 13 | $512 | $39 |
| Olanzapine | None | 13 | $405 | $31 |
| Modafinil | None | 18 | $386 | $21 |
| Sertraline | None | 36 | $379 | $11 |
| Hydroxyzine | None | 13 | $353 | $27 |
| Trazodone | None | 45 | $328 | $7 |
| Risperidone | None | 12 | $299 | $25 |
| Divalproex | None | 11 | $234 | $21 |
| Fluoxetine | None | 14 | $172 | $12 |
| Clonazepam | None | 20 | $161 | $8 |
| Lorazepam | None | 42 | $81 | $2 |
| Alprazolam | None | 32 | $64 | $2 |
Year by year
| 2024 | 858 | 67 | 0% (0) | 5% | $113,638 |
| 2023 | 586 | 48 | 0% (0) | 6% | $112,039 |
| 2022 | 297 | 34 | 0% (0) | 4% | $18,187 |
| 2021 | 101 | 11 | 0% (0) | None | $2,015 |
| 2020 | 16 | None | 0% (0) | 0% | $222 |
| 2014 | 61 | 22 | 0% (0) | 0% | $2,126 |
| 2013 | 855 | 83 | 0% (0) | 9% | $62,150 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Nuplazid | Parkinson's psychosis | 15 | $74,782 | $4,985 |
| Aripiprazole | None | 28 | $2,470 | $88 |
| Bupropion Xl | None | 62 | $2,420 | $39 |
| Duloxetine | None | 43 | $1,375 | $32 |
| Desvenlafaxine Succinate Er | None | 20 | $1,346 | $67 |
| Venlafaxine Hcl Er | None | 37 | $908 | $25 |
| Quetiapine | None | 15 | $874 | $58 |
| Lamotrigine | None | 29 | $741 | $26 |
| Gabapentin | None | 27 | $701 | $26 |
| Mirtazapine | None | 22 | $606 | $28 |
| Sertraline | None | 20 | $460 | $23 |
| Escitalopram | None | 26 | $398 | $15 |
| Buspirone | None | 23 | $334 | $15 |
| Trazodone | None | 16 | $187 | $12 |
| Clonazepam | None | 16 | $138 | $9 |
| Lorazepam | None | 26 | $115 | $4 |
| Alprazolam | None | 32 | $60 | $2 |
2022: 11 drugs
| Aripiprazole | 19 | $2,166 | $114 |
| Duloxetine | 39 | $1,110 | $28 |
| Bupropion Xl | 23 | $638 | $28 |
| Bupropion Hcl Sr | 12 | $232 | $19 |
| Mirtazapine | 11 | $227 | $21 |
| Lamotrigine | 23 | $227 | $10 |
| Sertraline | 28 | $166 | $6 |
| Escitalopram | 11 | $122 | $11 |
| Buspirone | 16 | $76 | $5 |
| Clonazepam | 14 | $34 | $2 |
| Lorazepam | 18 | $21 | $1 |
2021: 5 drugs
| Olanzapine | 12 | $559 | $47 |
| Trazodone | 15 | $208 | $14 |
| Bupropion Xl | 14 | $203 | $15 |
| Topiramate | 12 | $145 | $12 |
| Sertraline | 14 | $135 | $10 |
2013: 21 drugs
| Abilify | 28 | $27,514 | $983 |
| Quetiapine | 47 | $5,196 | $111 |
| Venlafaxine | 41 | $2,389 | $58 |
| Gabapentin | 42 | $1,394 | $33 |
| Fluoxetine | 36 | $1,225 | $34 |
| Bupropion Xl | 23 | $1,224 | $53 |
| Venlafaxine Hcl Er | 39 | $1,203 | $31 |
| Buspirone | 32 | $1,078 | $34 |
| Bupropion Hcl Sr | 22 | $849 | $39 |
| Lamotrigine | 41 | $614 | $15 |
| Divalproex | 18 | $574 | $32 |
| Mirtazapine | 45 | $558 | $12 |
| Topiramate | 16 | $505 | $32 |
| Clonazepam | 72 | $418 | $6 |
| Escitalopram | 13 | $413 | $32 |
| Prazosin | 12 | $411 | $34 |
| Citalopram Hbr | 50 | $318 | $6 |
| Lorazepam | 56 | $309 | $6 |
| Trazodone | 50 | $274 | $5 |
| Zolpidem | 24 | $119 | $5 |
| Clonidine | 14 | $101 | $7 |
Money from drug and device companies
$929 in 2025
| 2025 | 12 | 38 | None | $929 |
| 2024 | 3 | 3 | None | $64 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| E.R. Squibb & Sons L.L.C. | Cobenfy | $190 | 8 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $157 | 6 payments
|
| Alkermes | Aristada | $142 | 6 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $93 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $93 | 4 payments
|
| Vanda Pharmaceuticals | Fanapt | $52 | 2 payments
|
See all 38 published payments
| Tris Pharma | Meals · 2025-12-16 | Dyanavel Xr | $24 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-12-09 | Cobenfy | $23 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-02 | Caplyta | $23 |
| Alkermes | Meals · 2025-11-26 | Aristada | $23 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-20 | Caplyta | $24 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-10-21 | Trintellix | $22 |
| Alkermes | Meals · 2025-10-17 | Aristada | $22 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-14 | Cobenfy | $31 |
| Janssen Pharmaceuticals | Meals · 2025-10-08 | Invega Sustenna | $25 |
| Teva Pharmaceuticals USA | Meals · 2025-10-01 | Uzedy | $43 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-23 | Caplyta | $28 |
| Tris Pharma | Meals · 2025-09-17 | Dyanavel Xr | $21 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-02 | Cobenfy | $20 |
| Vanda Pharmaceuticals | Meals · 2025-08-21 | Fanapt | $30 |
| Teva Pharmaceuticals USA | Meals · 2025-08-19 | Austedo Xr | $30 |
| Alkermes | Meals · 2025-08-15 | Aristada | $21 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-12 | Cobenfy | $25 |
| Alkermes | Meals · 2025-07-30 | Aristada | $27 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-22 | Caplyta | $28 |
| Otsuka America Pharmaceutical | Meals · 2025-07-15 | Rexulti | $20 |
| Vanda Pharmaceuticals | Meals · 2025-07-09 | Fanapt | $22 |
| Alkermes | Meals · 2025-06-25 | Aristada | $26 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-06-17 | Trintellix | $16 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-10 | Caplyta | $29 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-05-13 | Trintellix | $27 |
| E.R. Squibb & Sons L.L.C. | Education · 2025-05-06 | Cobenfy | $27 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-06 | Cobenfy | $26 |
| Lundbeck | Meals · 2025-04-30 | Rexulti | $27 |
| Janssen Pharmaceuticals | Meals · 2025-04-22 | Invega Sustenna | $27 |
| Teva Pharmaceuticals USA | Meals · 2025-04-16 | Austedo Xr | $20 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-08 | Cobenfy | $19 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-03-25 | Caplyta | $26 |
| Collegium Pharmaceutical | Meals · 2025-03-18 | Jornay Pm | $21 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-03-11 | Trintellix | $27 |
| Supernus Pharmaceuticals | Meals · 2025-03-04 | Qelbree | $17 |
| Alkermes | Meals · 2025-02-19 | Aristada | $23 |
| Otsuka America Pharmaceutical | Meals · 2025-02-11 | Rexulti | $20 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-04 | Cobenfy | $18 |
See earlier years (2024)
2024: $64
| Alkermes | Aristada | $22 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $21 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | None | $21 | 1 payment
|
Professional record
- NPI
- 1982910485
- Licence
- CA 95005536
- Trained
- Yale University School of Medicine, 2010 · 16 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X)
- Mailing address
- 3835 N Freeway Blvd Ste 100, Sacramento, CA, 95834
- NPI first listed
- 2010-08-23
- NPI last updated
- 2026-04-29
- NPI record certified
- 2026-04-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 39199 Liberty St., Fremont, CA, 94538